Physician profile
Krista E Wiley
NPI 1154805737
$3,389.44
in general payments reported to CMS, 2019-2025
23 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $812 · 2022: $873 · 2023: $576 · 2024: $698 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $746.02 | 2021-2024 | |
| Astellas Pharma US INC | $480.80 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $374.36 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $330.96 | 2021-2025 | |
| Pfizer INC. | $296.63 | 2021-2024 | |
| Myovant Sciences INC. | $212.88 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $187.72 | 2023-2025 | Myfembree, Gemtesa |
| Biogen, INC. | $128.57 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $116.91 | 2021 | |
| Hologic Sales and Service, LLC | $114.95 | 2023-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Agile Therapeutics, INC. | $91.42 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $68.97 | 2021-2024 | Slynd |
| Daiichi Sankyo INC. | $57.16 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $28.04 | 2021 | |
| Merck Sharp & Dohme LLC | $20.39 | 2024 | Gardasil 9, Gardasil |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $20.27 | 2025 | |
| Heron Therapeutics, INC. | $18.01 | 2022 | |
| Dexcom, INC. | $18.00 | 2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $17.06 | 2021 | |
| Gynesonics, INC. | $15.95 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $15.63 | 2025 | The Cologuard Plus Collection Kit |
| Minerva Surgical, INC | $14.47 | 2024 | |
| Convatec INC. | $14.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.